
Overview
The goal of the project is to identify recurrent genetic alterations (mutations, deletions, amplifications, rearrangements) and/or gene expression signatures. National Cancer Institute (NCI) utilized whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing. The samples were processed and submitted for genomic characterization using pipelines and procedures established within The Cancer Genome Analysis (TCGA) project.
Features and programs
Open Data Sponsorship Program
Pricing
This is a publicly available data set. No subscription is required.
How can we make this page better?
Legal
Content disclaimer
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Open data resources
Available with or without an AWS account.
- How to use
- To access these resources, reference the Amazon Resource Name (ARN) using the AWS Command Line Interface (CLI). Learn more
- Description
- RNA-Seq Gene Expression Quantification
- Resource type
- S3 bucket
- Amazon Resource Name (ARN)
- arn:aws:s3:::gdc-ctsp-phs001175-2-open
- AWS region
- us-east-1
- AWS CLI access (No AWS account required)
- aws s3 ls --no-sign-request s3://gdc-ctsp-phs001175-2-open/
Resources
Vendor resources
Support
Contact
How to cite
Clinical Trial Sequencing Project - Diffuse Large B-Cell Lymphoma was accessed on DATE from https://registry.opendata.aws/ctsp-dlbcl .
License
NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies
Similar products




